Table 4.
Antibiotics | Number of isolates (%) | ||
---|---|---|---|
Susceptible | Intermediate | Resistant | |
Amikacin (30 μg) | 23(100) | 0(0) | 0(0) |
Gentamycin(10 μg) | 19(83) | 0(0) | 4(17) |
Streptomycin(25 μg) | (15)65 | 0(0) | 8(35) |
Chloramphenicol(30 μg) | 20(87) | 0(0) | 3(13) |
Tetracyclin(30 μg) | 19(83) | 0(0) | 4(17) |
Ciprofloxacin(5 μg) | 21(91) | 1(4.5) | 1(4.5) |
Gatifloxacin(5 μg) | 19(83) | 2(8.5) | 2(8.5) |
Moxifloxacin(5 μg) | 17(74) | 3(13) | 3(13) |
Imipenem(10 μg) | 19(83) | 0(0) | 4(17) |
Meropenem(10 μg) | 23(100) | 0(0) | 0(0) |
Ertapenem(10 μg) | 23(100) | 0(0) | 0(0) |
Ampicillin(30 μg) | 3(13) | 0(0) | 20(87) |
Penicillin G(10 μg) | 1(4.5) | 1(4.5) | 21(91) |
Linezolid(30 μg) | 18(78) | 0(0) | 5(22) |
Aztreonam(30 μg) | 21(91) | 0(0) | 2(9) |
Erythromycin(15 μg) | 4(17) | 0(0) | 19(83) |
Cephalothin(30 μg) | 17(74) | 1(4) | 5(22) |
Ceftriaxone(30 μg) | 21(91) | 1(4.5) | 1(4.5) |
Sulphamethoxazole (25 μg) | 8(35) | 0(0) | 15(65) |
Trimethoprim(5 μg) | 17(74) | 0(0) | 6(26) |